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ABSTRACT: Recent advances in polymer science are
enabling substantial progress in nanobiotechnology, partic-
ularly in the design of new tools for enhanced understanding
of cell biology and for smart drug delivery formulations.
Herein, a range of novel galactosylated diblock copolymer
nano-objects is prepared directly in concentrated aqueous
solution via reversible addition−fragmentation chain transfer
polymerization using polymerization-induced self-assembly.
The resulting nanospheres, worm-like micelles, or vesicles
interact in vitro with galectins as judged by a turbidity assay. In
addition, galactosylated vesicles are highly biocompatible and allow intracellular delivery of an encapsulated molecular cargo.
■ INTRODUCTION
Controlled radical polymerization (CRP) techniques have
enabled synthetic chemists to prepare a remarkably wide
range of functional copolymers.1 Glycopolymers2 have
particularly beneﬁted from the versatility oﬀered by CRP
syntheses, with many well-deﬁned architectures3 (e.g., block,4
surface grafting,5 hyperbranched,6 or dendritic7) being
reported. Indeed, glycosylated macromolecules and nano-
objects are very promising tools to study biological processes
and/or design novel therapeutics in the ﬁeld of nano-
biotechnology.8−11 Glycotargeting exploits interactions of
speciﬁc glycan receptors with carbohydrate ligands. Given the
vast density of information that sugars can encode, these
interactions oﬀer enhanced speciﬁcity and aﬃnity compared to
many other ligand-binding systems.12 Glycotargeting was ﬁrst
demonstrated more than four decades ago.13 However, despite
its manifest advantages, the therapeutic potential of glycotarget-
ing strategies has yet to be properly exploited. Of particular
relevance to the present study is the design of galectin-binding
nanoparticles, for which there are a growing number of
biological applications. Mammalian galectins are a family of
lectins that exhibit strong aﬃnity for β-galactose-containing
glycoconjugates.14 All galectins share a core sequence
consisting of about 130 amino acids, many of which are highly
conserved. This core sequence is known as the carbohydrate
recognition domain (CRD) and is responsible for the binding
of speciﬁc sugars.15 The biological signiﬁcance of speciﬁc
carbohydrate-ligand recognition by various galectins is not fully
understood, but this may in part explain why individual
galectins preferentially bind to diﬀerent glycoprotein counter-
receptors, which implies speciﬁc targeting. Galectins are
ubiquitous within the cell and are highly mobile; they can be
found in the cytosol and nuclear region and, although secretion
signal peptides have not been found in the sequence of
galectins, they are also present in the extracellular space.16 It
appears that galectins may be targeted for secretion by
nonclassical mechanisms, possibly by direct translocation across
the plasma membrane.15 Galectins bind to the cell-surface and
extracellular matrix glycans and are known to play key roles in
numerous cellular processes, such as apoptosis, cell adhesion17
and receptor turnover and endocytosis.18 Galectins also have
important functions in many physiological and pathological
processes, including immune and inﬂammatory responses,18
tumorigenesis,19 neural degeneration, atherosclerosis, and
wound repair.15 Furthermore, galectin-mediated cellular
receptor internalization and recycling processes are very
rapid. Moreover, although the precise internalization mecha-
nism remains unknown, it appears to avoid the degradative
environment of the endosomes.20 Thus, galectin targeting has
the potential to oﬀer new therapeutic avenues for nano-
medicine.
The self-assembly of amphiphilic diblock copolymers21
allows access to a wide range of nano-objects, such as spherical
micelles,22 worm-like micelles,23,24 and vesicles,22,25−27 which
have applications in nanomedicine, cell biology, electronics, and
energy.28−30 For example, self-assembled glycopolymer-based
nano-objects are very attractive for the development of novel
gene delivery vectors and vaccines.31 Block copolymer nano-
objects are typically obtained via postpolymerization processing
of soluble copolymer chains using traditional solvent switch,22
pH switch32 or thin ﬁlm rehydration techniques.33 These
techniques have been successfully employed to prepare a range
of self-assembled nanostructures based on glycopolymers.34 Li
et al. reported one of the ﬁrst examples of glycosylated self-
assembled polymeric morphologies using polystyrene-b-poly-
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[(2-β-D-glucopyranosyloxy)ethyl acrylate] block copolymers
obtained by atom transfer radical polymerization (ATRP).4
Similarly, Alexander and Pasparakis prepared temperature-
sensitive glucose-decorated vesicles from a double-hydrophilic
block copolymer obtained by ATRP and reversible addition−
fragmentation chain transfer (RAFT) polymerization and
demonstrated that these glycosylated vesicles strongly interact
with bacteria that express glucose-binding proteins on their
surface.31b Hedrick, Dubois, Yang and co-workers reported the
formation of new biodegradable polycarbonate-based micelles
displaying either glucose or galactose surface moieties via self-
assembly in aqueous media.35 Schlaad reported the formation
of well-deﬁned glycosylated morphologies by aqueous self-
assembly of partially glycosylated 1,2-polybutadiene-b-polystyr-
ene36 and 1,2-polybutadiene-b-poly(ethylene oxide)37 prepared
by a combination of thiol−ene chemistry and anionic
polymerization. Interestingly, the latter vesicles possessed
asymmetric membranes, with the poly(ethylene oxide) chains
being conﬁned to the inner surface, while the sugar moieties
were expressed at the outer surface. Lecommandoux and Heise
utilized the ring-opening polymerization of N-carboxyanhy-
drides to synthesize glycosylated peptide-based block copoly-
mers that formed well-deﬁned spherical, worm-like micelles or
vesicles in aqueous solution.38 Finally, rod−coil glycosylated
block copolymer self-assembly in water has also been
demonstrated for biosensor applications.39
However, such traditional self-assembly strategies invariably
only allow the formation of block copolymer nano-objects in
relatively dilute solution (<1%). In contrast, the recent
introduction of polymerization-induced self-assembly (PISA)
formulations based on RAFT polymerization40 enables well-
deﬁned block copolymer nano-objects to be prepared directly
at up to 25% solids without recourse to any postpolymerization
processing.41,42
Herein we exploit this PISA approach to prepare a range of
new galactose-functionalized diblock copolymer nano-objects
that interact in vitro with galactose-speciﬁc lectins. The eﬀect of
copolymer morphology on the sensitivity of a simple
turbidimetric binding assay is explored. Furthermore, encapsu-
lation of a molecular cargo and eﬀective intracellular delivery
while escaping the endolysosome environment are also
demonstrated.
■ MATERIALS AND METHODS
All reagents were purchased from Sigma-Aldrich (U.K.) and were used
as received, unless otherwise noted. 4,4′-Azobis-4-cyanopentanoic acid
(ACVA, >98%) was used as an initiator. 2-Hydroxypropyl
methacrylate (HPMA, 97%) was kindly donated by GEO Specialty
Chemicals (Hythe, U.K.) and comprises ∼75% 2-hydroxypropyl
methacrylate and 25 mol % 2-hydroxyisopropyl methacrylate.
According to HPLC analysis, this monomer also contained about
0.10 mol % dimethacrylate impurity. All solvents were purchased from
Fisher Scientiﬁc (U.K.) as HPLC grade and were used as received.
Deionized water was used in all experiments. Silica gel 60 (0.0632−0.2
mm) was obtained from Merck (Darmstadt, Germany). All NMR
solvents (D2O and CD3OD) were purchased from Goss Scientiﬁc
Instruments Ltd. (U.K.). Dialysis membrane (molecular weight cutoﬀ,
MWCO = 1000) was purchased from Fisher Scientiﬁc (U.K.). The
PETTC RAFT agent was prepared as described previously.41c
Synthesis of Galactose Methacrylate (GalSMA). 1-Thio-β-D-
galactose (GalSH) was ﬁrst prepared according to the method
described by Floyd et al.43 in an overall yield of 70%. GalSH (5.00 g,
25.48 mmol) was placed in a round-bottomed ﬂask and dissolved in
DMF (15 mL). A solution of 3-(acryloyloxy)-2-hydroxypropyl
methacrylate (6.00 g, 28.03 mmol) in DMF (5.0 mL) was then
added to this GalSH solution. Dimethylphenylphosphine (10 μL, 7.0
× 10−2 mmol) was then added to the reaction solution. After 30 min,
the DMF solution was precipitated into excess diethyl ether. The
viscous residue was dissolved in DMF and precipitated again into
diethyl ether. The resulting viscous oil was then puriﬁed by ﬂash
chromatography using 9:1 methanol/dichloromethane, and this
solvent mixture was then evaporated under vacuum. The monomer
was not isolated but instead was stored at −20 °C as a 77 wt %
concentrated solution in methanol. After puriﬁcation, the yield was
estimated by 1H NMR to be around 90%. The overall yield based on
β-D-galactose pentaacetate was 63%. 1H NMR (400.13 MHz, D2O,
298 K) δ (ppm): 1.93 (s, 3H, -CH3); 2.83 (t, 2H, -CH2-COO); 2.92−
3.06 (m, 2H, -CH2-S); 3.54 (t, 1H, H2); 3.61−3.64 (dd, 1H, H3);
3.67−3.82 (m, 4H, H5, H6, -CH2-CHOH-CH2-); 3.96 (d, 1H, H4);
4.20−4.30 (m, 4H, -CH2-CHOH-CH2-); 4.48 (d, 1H, H1); 5.73 (s,
1H, vinyl), 6.16 (s, 1H, vinyl). 13C NMR (400.13 MHz, D2O, 298 K) δ
(ppm): 18.0 (CH3-); 25.8 (-S-CH2); 35.5 (-S-CH2-CH2-); 61.6 (C6);
65.9 (2C, -CH2-CHOH-CH2-); 67.5, 69.4, 70.2, 74.5, 79.5, 86.7 (6C,
C1, C2, C3, C4, C5, -CH2-CHOH-CH2-); 127.8, 136.2 (2C, vinyl),
169.9, 174.7 (2C, carbonyls). (M + H+): calcd mass = 411.1307, actual
mass found = 411.1325.
RAFT Homopolymerization of GalSMA. GalSMA (10.65 g of a
77 wt.% methanolic solution; 8.20 g, 19.97 mmol) was placed in a
round-bottomed ﬂask containing a magnetic bar, PETTC (0.226 g,
666 μmol), and ACVA (18.60 mg, 66.4 μmol; PETTC/ACVA molar
ratio = 10). Phosphate buﬀer solution (22.15 g, 150 mM, pH 7.2) was
added, and the ﬁnal solution was degassed by nitrogen bubbling. After
30 min, the round-bottomed ﬂask was placed in a preheated oil bath at
70 °C. The reaction was quenched after 150 min (97% conversion),
and the polymer was puriﬁed by dialysis (MWCO = 1000) against
deionized water, followed by freeze-drying overnight. DMF GPC
analysis gave Mn = 16 300 g mol
−1, Mw/Mn = 1.13. End-group analysis
via 1H NMR spectroscopy indicated a mean degree of polymerization
of 34 (Mn = 14 300 g mol
−1), which corresponds to a RAFT CTA
eﬃciency of 85% for the PETTC.
RAFT Homopolymerization of Glycerol Monomethacrylate
(GMA). GMA (7.00 g, 43.70 mmol) was added to a round-bottomed
ﬂask containing a magnetic bar, PETTC (269.78 mg, 795.00 μmol),
and ACVA (22.27 mg, 79.50 μmol). Ethanol (7.00 g) was added to
this solution, which was then degassed by nitrogen bubbling. After 30
min, the round-bottomed ﬂask was placed in a preheated oil bath at 70
°C. The polymerization was quenched after 5 h (conversion = 88%),
the polymer was puriﬁed by dialysis (MWCO = 1000) against
deionized water, and freeze-dried overnight. DMF GPC analysis
indicated Mn = 16 200 g mol
−1 and Mw/Mn = 1.15. End-group analysis
using 1H NMR gave a mean degree of polymerization of 51 (Mn =
8500 g mol−1). This indicated a RAFT CTA eﬃciency of 94% for the
PETTC.
Polymerization-Induced Self-Assembly (PISA). A typical
RAFT aqueous dispersion polymerization was performed as follows:
HPMA (377.0 mg, 2.61 mmol, target DP = 201) and deionized water
(1.78 mL) were added to a sample vial containing a magnetic stir bar,
PGMA51 macro-CTA (100 mg, 11.7 μmol), PGalSMA34 macro-CTA
(18.7 mg; 1.31 μmol), and ACVA initiator (200 μL of a 13.0 mM
aqueous solution; macro-CTA/initiator molar ratio = 5.0). The
reaction solution was degassed by nitrogen bubbling for 15 min and
then placed in a preheated oil bath at 70 °C. The polymerization was
quenched after 6 h (>99% conversion, as judged by 1H NMR
spectroscopy). Similar polymerizations were conducted targeting
alternative PHPMA block lengths, which allowed access to either
spherical, worm-like, or vesicular copolymer morphologies. See note in
the Supporting Information.
Gel Permeation Chromatography (GPC). Homopolymer and
diblock copolymer molecular weight distributions were determined by
DMF GPC. The GPC setup comprised two Polymer Laboratories PL
gel 5 μm Mixed-C columns maintained at 60 °C in series with a Varian
390 LC refractive index detector. The ﬂow rate was 1.0 mL min−1, and
the mobile phase contained 10 mM LiBr. Ten near-monodisperse
PMMA standards (Mp = 625−618 000 g mol−1) were used for
calibration.
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1H NMR Spectroscopy. All 1H NMR and 13C NMR spectra were
recorded in either CD3OD, d6-DMSO, or D2O using either a 250 MHz
Bruker Avance 250 or a 400 MHz Bruker Avance 400 spectrometer.
Transmission Electron Microscopy. TEM images were acquired
using a Philips CM100 instrument operating under UHV at 100 kV.
To prepare TEM samples, 5.0 μL of a dilute aqueous copolymer
solution was placed onto a carbon-coated copper grid, stained using
uranyl formate, and then dried under ambient conditions.
Dynamic Light Scattering. DLS measurements were conducted
at 25 °C using a scattering angle of 173° with a Malvern Instruments
Zetasizer Nanoseries instrument equipped with a 4 mW He−Ne laser
operating at 633 nm, an avalanche photodiode detector with high
quantum eﬃciency, and an ALV/LSE-5003 multiple t digital correlator
electronics system. The intensity-average diameter and polydispersity
of the diblock copolymer particles were calculated by cumulants
analysis of the experimental correlation function using Dispersion
Technology Software version 6.20.
Rheology Studies. The storage modulus (G′) and loss modulus
(G′′) curves for the (1:9 PGalSMA34 + PGMA51)-PHPMA150 diblock
copolymer worm gel were determined using a TA Instruments AR-G2
rheometer equipped with a Peltier heating/cooling plate. A cone-and-
plate geometry (40 mm, 2° aluminum cone) was used for the
measurements. Temperature sweeps were conducted at a ﬁxed strain
of 1.0% using an angular frequency of 1 rad s−1. Stepwise sweeps were
conducted at increments of 1 °C, using an equilibration time of 3 min
for each step and an equilibration time of 5 min at 25 and 1 °C.
UV−vis Spectroscopy. Turbidimetry studies were conducted at
20 °C using a Cary 50 UV−vis spectrophotometer at a wavelength of
420 nm. All lectin interaction studies were performed in HEPES buﬀer
(HEPES 10 mM, NaCl 150 mM, MnCl2 1 mM, CaCl2 1 mM) at pH
7.4. For the lectin assay, a cuvette containing 0.50 mL of a 2 µM
solution of RCA120 in HEPES buﬀer was placed in the spectrometer.
0.50 mL of a 1.0 wt% aqueous diblock copolymer dispersion was
added to the cuvette, and the absorbance at 420 nm was monitored
over time. For the negative control, a cuvette containing 0.50 mL of a
2 µM solution of RCA120 in HEPES buﬀer was placed in the
spectrometer. 0.50 mL aliquots of 50 µM homopolymer solutions
(either PGMA51 or PGalSMA34, see Figure S5) were added to the
cuvette, and the absorbance at 420 nm was monitored over time.
Preparation of Sterile (1:9 PGalSMA34 + PGMA51)-PHPMA270
Vesicles via Film Rehydration. Copolymers were dissolved in a
2:1% v/v methanol/chloroform mixture to form a 1 mM solution. A
0.05 mM Rhodamine B octadecyl ester perchlorate (Sigma-Aldrich)
solution in 2:1% v/v methanol/chloroform mixture was prepared.
Equal volumes of these two solutions were mixed, the resulting
solution was then ﬁlter-sterilized using a 0.20 μm Nylon ﬁlter
(Millipore), and the solvent mixture evaporated under sterile
conditions to form a thin copolymer ﬁlm. This ﬁlm was subsequently
rehydrated under sterile conditions using phosphate buﬀer saline (100
mM PBS) at pH 7.4 with constant stirring for 5 days to form a 1.0%
w/w copolymer suspension. The vesicle dispersion was sonicated daily
for up to 30 min under controlled temperature (20 °C). Vesicles were
puriﬁed via preparative GPC, using a size exclusion column containing
Sepharose 4B and using PBS at pH 7.4 as an eluent.
Cell Culture. Primary human dermal ﬁbroblasts (HDFs) were
obtained from LGC standards (Teddington, U.K.). Cells were
maintained in DMEM (Biosera, U.K.) supplemented with 10% v/v
fetal calf serum, 2 mM L-glutamine, 100 IU/mL penicillin, 100 mg/mL
streptomycin, and 0.625 μg/mL amphotericin B (all from Sigma-
Aldrich, U.K.). Cells were subcultured routinely using 0.02% (w/v)
trypsin-EDTA (Sigma-Aldrich, U.K.) and used for experimentation
between passages 4 and 8.
Cell Viability via MTT-ESTA Assay. The well-known 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)
assay was used to measure cellular metabolic potential of treated
cells after exposure to nanovesicles.44 Brieﬂy, 3−4 × 104 HDF cells per
well were cultured in 24-well plates until 70% conﬂuence (typically 48
h). Cells were incubated for 24 h with varying concentrations of
vesicles. After treatment, cell cultures were thoroughly washed in PBS
and then incubated with MTT solution (0.50 mg/mL MTT in PBS,
1.0 mL per well for 24-well plates) for 45 min at 37 °C and in a 95%
air/5% CO2 environment. Intracellular dehydrogenase activity reduces
MTT to form a purple formazan salt. After 45 min, the solution was
aspirated, and the insoluble intracellular formazan product was
solubilized and released from cells by adding acidiﬁed isopropanol
(0.30 mL per well of 24-well plate or 1 mL per cm−2 cultured tissue)
and incubated for 10 min. The optical density at 570 nm was then
recorded using a plate reading spectrophotometer (with a reference
ﬁlter at 630 nm). For statistical analysis (student’s t test), experiments
were performed in triplicate wells with a total of N = 3 independent
experiments.
Live Fluorescence Microscopy Imaging of the Cellular
Uptake of Sterilized (1:9 PGalSMA34 + PGMA51)-PHPMA270
Vesicles Loaded with Rhodamine B Octadecyl Ester. Cells
were seeded at a density of 5 × 103 cells/well in BD Falcon 96-well
imaging plates and grown until 50% conﬂuence. Cells were treated
overnight (typically 16 h) with a 1.0 mg/mL aqueous vesicle
dispersion encapsulating ∼10 μmol of rhodamine B octadecyl ester
perchlorate (Sigma-Aldrich, U.K.) per mmol of copolymer solution.
The cells were washed three times with PBS and nuclei stained using
1.0 μg/mL of Hoechst 33342 solution (Thermo Scientiﬁc, U.K.) for
10 min. Stained cells were washed once more, and imaging medium
(culture medium without phenol red) was added to each well for
subsequent live imaging experiments, which were performed using a
Zeiss LSM510 Meta instrument (40× magniﬁcation).
■ RESULTS AND DISCUSSION
The synthesis, isolation, and puriﬁcation of glycomonomers is
notoriously diﬃcult. For the present study, a novel route to a
methacrylic glycomonomer was devised. This method (see
Figure 1a) relies on the very high eﬃciency and regioselectivity
oﬀered by thia-Michael addition to acrylates.45 1-Thio-β-D-
galactose was readily prepared on a multigram scale according
to literature protocols43 and subsequently reacted with 3-
(acryloyloxy)-2-hydroxypropyl methacrylate to produce the
desired galactose methacrylate (GalSMA) in 63% yield (Figure
Figure 1. (a) Synthesis of a new GalSMA monomer via thia-Michael
addition. (b) Preparation of self-assembled block copolymer nano-
objects (spheres, worms or vesicles) via PISA of HPMA using a binary
mixture of RAFT macro-CTAs based on PGMA and PGalSMA.
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S1). GalSMA tends to autopolymerize during long-term
storage, hence this monomer was kept under nitrogen at −20
°C as a concentrated methanolic solution and utilized shortly
after its synthesis. PGalSMA was synthesized by RAFT
polymerization in a 9:1 mixture of PBS buﬀer (150 mM, pH
7.2) and methanol at 70 °C using a trithiocarbonate-based
PETTC (4-cyano-4-(2-phenylethane sulfanylthiocarbonyl) sul-
fanylpentanoic acid)41c RAFT agent and ACVA (4,4′-azobis(4-
cyanopentanoic acid)) initiator. This aﬀorded a well-deﬁned
PGalSMA34 macro-CTA (Figure S2), which was then chain-
extended using HPMA under RAFT aqueous dispersion
polymerization conditions.41
When PGalSMA34 was used as the sole macro-CTA, self-
assembled spherical nanoparticles, worm-like micelles, or
vesicles were obtained, depending on the target diblock
copolymer composition and the copolymer concentration
(Figure S3). Well-deﬁned spherical nanoparticles were readily
formed over a wide range of reaction conditions, but the other
two morphologies were generally only obtained as components
of mixed phases. In particular, when targeting DPs of around
700 for the core-forming PHPMA block, large vesicles and
tubular structures featuring relatively thick walls were often
observed as major components of these mixtures (Figure S3).
However, according to the literature46 biological activity is
unlikely to require surface expression of a high density of
galactose residues. Thus a binary mixture of PGalSMA34 and
poly(glycerol methacrylate) (PGMA51) macro-CTAs was
utilized for the RAFT aqueous dispersion polymerization of
HPMA (Figure 1b). We have previously reported that using
binary mixtures of a nonionic and a polyelectrolytic macro-
CTA leads to hybrid nano-objects with mixed coronal stabilizer
layers.41c,d As the HPMA polymerization progressed, the
initially homogeneous aqueous milieu gradually became ﬁrst
translucent and then increasingly turbid, depending on the
mean DP targeted for the core-forming PHPMA block. This
turbidity corresponds to the onset of copolymer aggregation;
such nucleation is usually accompanied by an enhanced rate of
polymerization, which is believed to be due to the preferential
partitioning of unreacted HPMA monomer within the growing
micellar aggregates.41,42a These RAFT syntheses proved to be
both eﬃcient and well-controlled: >99% monomer conversion
and low copolymer polydispersities were routinely achieved as
judged by 1H NMR and DMF GPC studies (Figure S4 and
Table S1). The mean DP of the PHPMA block and the
copolymer solids content were systematically varied to
construct a phase diagram that enables the reproducible
preparation of morphologically pure nano-objects (Figure 2a).
Representative TEM images for the various galactose-function-
alized nano-objects are shown in Figure 2b. Using a 1:9 binary
mixture of PGalSMA34 and PGMA51 macro-CTAs produces
well-deﬁned spherical, worm-like, or vesicular phases as well as
various mixed phases. The (1:9 PGalSMA34 + PGMA51)-
PHPMA150 worm-like micelles
47 form translucent free-standing
gels at 20 °C similar to those previously reported for PGMA-
PHPMA diblock copolymers.48 However, cooling to 3 °C leads
to degelation, with the gel phase reforming on returning to
Figure 2. (a) Phase diagram constructed for (1:9 PGalSMA34 + PGMA51)-PHPMAx diblock copolymer nano-objects prepared by RAFT aqueous
dispersion polymerization at 70 °C. The target PHPMA DP and the total solids content were systematically varied and the post mortem copolymer
morphologies obtained at >98% HPMA conversion were determined by TEM. N.B. S, SW, W, V, and FS denote spheres, short worm-like micelles,
worm-like micelles, vesicles, and frustrated (i.e., kinetically trapped) spheres, respectively. (b) Representative TEM images obtained for (1:9
PGalSMA34 + PGMA51)-PHPMAx copolymer nano-objects prepared by RAFT aqueous dispersion polymerization of HPMA at 70 °C. The targeted
DP (x) for the PHPMA block (herein denoted by ‘H’ for brevity) and the copolymer solids content % is indicated on each image.
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ambient temperature. Rheology and DLS studies were
undertaken to further characterize this thermo-reversible
transition (Figure 3). More speciﬁcally, the temperature
dependence of the storage (G′) and loss (G′′) moduli was
monitored (Figure 3b) for a 20% w/w aqueous dispersion of
(1:9 PGalSMA34 + PGMA51)-PHPMA150 worm-like micelles.
For this particular dispersion, G′ exceeds G′′ between 25 and
7.5 °C, which indicates the formation of a soft viscoelastic gel.
Below 7.5 °C, G′ is reduced by ∼2 orders of magnitude and
these curves cross over; this is consistent with the formation of
a free-ﬂowing viscous liquid at 3 °C (Figure 3a). During the
heating cycle, crossover occurs at the same critical temperature,
which suggests minimal hysteresis. However, a somewhat
weaker ﬁnal gel is obtained, indicating some irreversibility. This
sol−gel transition is ascribed to the transformation of worm-
like micelles into spherical micelles upon cooling; such an
order−order transition has also been observed for PGMA-
PHPMA diblock copolymers.48 The molecular origin for this
sol−gel transition is the well-known thermoresponsive nature
of the PHPMA block.48 This leads to a subtle variation in the
degree of hydration of these hydrophobic chains, which in turn
causes a change in the molecular packing parameter that
dictates the overall copolymer morphology.48,49 DLS studies of
a 1.0% aqueous dispersion of (1:9 PGalSMA34 + PGMA51)-
PHPMA150 worm-like micelles are shown in Figure 3c,d.
The intensity-average diameter and scattered light intensity
are both signiﬁcantly reduced at lower temperature, suggesting
a worm-to-sphere morphological transition. This is consistent
with the observation of degelation, since, unlike anisotropic
worms, the isotropic spheres can no longer form multiple
interparticle entanglements/contacts. However, on allowing the
cold copolymer solution to warm up to ambient temperature,
the sphere-to-worm transition is not observed on the time scale
of the experiment. This is simply because of the reduced
probability of eﬃcient sphere−sphere 1D fusion at this
relatively low copolymer concentration.41b
The interaction of these new galactose-functionalized diblock
copolymer nano-objects with RCA120, a galactose-speciﬁc (and
N-acetylgalactosamine-speciﬁc) lectin, was then examined using
turbidimetry and DLS. Such lectin assays are well-established
and can be used to assess the bioavailability of the galactose
moieties on the surface of the self-assembled nano-objects. The
spheres, worm-like micelles and vesicles all interact strongly
with RCA120, leading to the rapid formation of much larger
aggregates (Figure 4). Moreover, control experiments conﬁrm
that PGalSMA34 homopolymer interacts strongly with RCA120,
whereas PGMA51 homopolymer produces no detectable
interaction (Figure S5). Taken together, these data indicate
that galactose residues are expressed at the surface of the
diblock copolymer nano-objects, as expected. It is also striking
that the galactose-functionalized worm-like micelles and
Figure 3. (a) Digital photographs recorded for a 20% w/w aqueous dispersion of (1:9 PGalSMA34 + PGMA51)-PHPMA150 worm-like micelles
recorded at (i) 20 °C (gel) and (ii) 3 °C (ﬂuid). (b) Variation of storage modulus (G′, black symbols) and loss modulus (G′′, red symbols) for the
same 20% w/w diblock copolymer worm gel during temperature cycling in 1 °C increments: (i) cooling from 25 to 1 °C (G′ = inverted black
triangles, G′′ = inverted red triangles) and (ii) subsequent warming from 1 to 25 °C in 1 °C increments (G′ = black triangles, G′′ = red triangles).
(c) and (d) Temperature-dependent DLS studies of the intensity-average diameter and scattered light intensity respectively, for the same aqueous
dispersion of diblock copolymer worms diluted to 1.0% w/w.
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vesicles are characterized by a much stronger (and faster)
optical response on exposure to RCA120 than the galactose-
functionalized spheres (Figure 4). This is important, because it
suggests that the copolymer morphology profoundly inﬂuences
the lectin assay sensitivity.
Finally, the interaction of galactose-functionalized vesicular
nano-objects with living cells was examined. (1:9 PGalSMA34 +
PGMA51)-PHPMA270 vesicles (synthesized by RAFT aqueous
dispersion polymerization at 15% solids) were dialyzed against
deionized water prior to freeze drying. Vesicles were then
generated via thin-ﬁlm rehydration. DLS measurements show
that the dimensions of such reconstituted vesicles are not
signiﬁcantly diﬀerent from that of the vesicles initially obtained
by PISA (see Figure S6). This puriﬁcation protocol ensured the
elimination of any potentially toxic volatile chemicals remaining
in the reaction solution at the end of the polymerization. PISA
syntheses conducted under sterile conditions are also now
under investigation and will be reported elsewhere in due
course. Vesicle biocompatibility, cellular uptake, and cargo
delivery studies were then performed on HDF cells. These
relatively delicate primary cells are a sensitive model for testing
nanoparticle-induced toxicity50 and are known to express
galectins.51 Cytotoxicity studies were performed using an
MTT-ESTA assay and conﬁrmed cell viabilities of >95%
when exposed to varying concentrations of vesicles for 24 h,
with no signiﬁcant diﬀerences compared to the untreated
control cells (Figure S7). These viability data conﬁrm that thin-
ﬁlm rehydration and the associated puriﬁcation steps eﬃciently
eliminate toxic solvents (e.g., chloroform and methanol) and
produce sterile, highly biocompatible vesicles that are suitable
for subsequent cell uptake studies.
Rhodamine B octadecyl ester-loaded (1:9 PGalSMA34 +
PGMA51)-PHPMA270 vesicles were avidly internalized by HDF
cells. Subsequent release of their ﬂuorescent dye cargo led to
extensive staining of the cell membranes (Figure 5). In the
absence of a suitable vesicle carrier, it is known that this
particular amphiphilic rhodamine dye cannot enter HDF
cells.52 Hence the observation of positive intracellular staining
conﬁrms both cellular uptake of the vesicles and intracellular
delivery of their dye cargo. Many membrane-rich organelles are
stained, such as the mitochondria and endocytic compartments.
This was not unexpected, as the mechanism of uptake of these
vesicles is likely to be endocytosis and rhodamine dyes have a
well-known aﬃnity for the mitochondria.53 However, staining
of the endomembrane system, including the nuclear membrane
(Figure 5c) and even co-staining within the nuclear region, was
also observed. Since the nuclear region lacks endolysosomal
compartments, this observation suggests the intracellular
release of the dye cargo and its escape from the normal
endocytic pathway.
Galectin-mediated receptor turnover is known to be a rapid
process that can potentially avoid degradation in the lysosomal
environment.20 Nevertheless, our observation of release of the
rhodamine dye from the vesicles and its subsequent location
outside the endocytic compartments (within the cell nuclei) is
rather surprising.
Previous work using other diblock copolymers containing
weakly hydrophobic PHPMA chains54 suggests that the stability
of such colloidal aggregates is concentration-dependent. Thus
reducing the aggregate concentration below the critical micelle
concentration of the copolymer leads to their spontaneous
dissociation to form molecularly dissolved copolymer chains.
Hence we suggest that dilution-triggered vesicle dissociation is
the most likely mechanism for the in situ release of the
rhodamine dye label within the cells. It is noteworthy that this
release mechanism is not necessarily exhibited by other
biocompatible methacrylic diblock copolymers comprising
signiﬁcantly more hydrophobic membrane-forming chains
than that utilized in the present study.55
Figure 4. Galactose-speciﬁc lectin interactions with three types of
galactose-functionalized diblock copolymer nano-objects (each origi-
nally prepared at 20% solids). (a) Turbidimetric assays for (1:9
PGalSMA34 + PGMA51)-PHPMA75 spheres (black curve), (1:9
PGalSMA34 + PGMA51)-PHPMA150 worm-like micelles (red curve),
and (1:9 PGalSMA34 + PGMA51)-PHPMA270 vesicles (blue curve).
DLS size distributions recorded for the same nano-objects: (b)
spheres, (c) worm-like micelles, and (d) vesicles, recorded both in the
absence (black curves) and presence (red curves) of RCA120. Assay
conditions: [RCA120] = 1 μM and [copolymer] = 0.50 wt % in 10 mM
HEPES buﬀer at pH 7.2.
Figure 5. Eﬀective intracellular delivery of rhodamine B octadecyl
ester in HDF cells mediated by (1:9 PGalSMA34 + PGMA51)-
PHPMA270 vesicles (prepared via thin ﬁlm rehydration to ensure
sterility and enable loading with a ﬂuorescent dye). Cells were
incubated for 16 h with 1.0 mg/mL rhodamine B octadecyl ester-
loaded vesicles. (a) Confocal microscopy image of live HDF cells: note
the intracellular staining of membranes (red) after exposure to the
rhodamine-loaded vesicles, cell nuclei are counter-stained blue using
Hoechst 33342. (b) HDF cells treated with the same vesicles
containing no rhodamine dye (negative control). (c) Higher
magniﬁcation image obtained for (a): eﬀective intracellular delivery
of rhodamine dye allows selective staining of the nuclear membrane
(white arrows). Scale bar: 50 μm.
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■ CONCLUSION
In summary, PISA has been exploited for the convenient
synthesis of a range of new glycopolymer-decorated block
copolymer nano-objects (spheres, worm-like micelles, or
vesicles) directly in concentrated aqueous solution. As
expected, these nano-objects interact strongly with galactose-
speciﬁc lectins in vitro, demonstrating high speciﬁcity. The
sensitivity of a simple turbidimetric lectin binding assay is
strongly dependent on the copolymer morphology: For a given
copolymer concentration, the use of vesicles and worms leads
to much greater turbidity than spherical nanoparticles.
Furthermore, galactosylated vesicles were rapidly taken up by
primary HDF cells with little or no cytotoxicity. Such vesicles
can encapsulate and subsequently release their payloads
intracellularly. These preliminary results may lead to new
opportunities for targeted drug delivery.
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